Kera Capital Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$822K Buy
3,347
+817
+32% +$178K 0.07% 224
2026
Q2
$493K Buy
2,530
+871
+53% +$181K 0.05% 326
2026
Q1
$372K Buy
1,659
+818
+97% +$204K 0.05% 341
2025
Q4
$217K Buy
841
+52
+7% +$13.3K 0.03% 506
2025
Q3
$216K Buy
+789
New +$216K 0.03% 386

Other funds holding RMD

Kera Capital Partners's RMD Position: Q3 2026 in Review

Kera Capital Partners increased its ResMed (RMD) stake by 32% in Q3 2026, buying an estimated $178K and bringing the position to 3,347 shares worth $822K. The position accounts for 0.07% of the portfolio, ranked #224.

Kera Capital Partners first reported a position in RMD in Q3 2025 and has held it in 5 quarters since. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Kera Capital Partners held 3,347 shares of ResMed worth $822K as of Q3 2026.
  • Kera Capital Partners bought 817 ResMed shares in Q3 2026, an estimated $178K.
  • ResMed made up 0.07% of Kera Capital Partners's portfolio in Q3 2026, its #224 holding.
  • Kera Capital Partners first reported a position in ResMed in Q3 2025 and has held it in 5 quarters since.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Kera Capital Partners's 13F filing for Q3 2026, filed 13 Nov 2026.